220 related articles for article (PubMed ID: 24486195)
1. Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism.
Andreadou I; Mikros E; Ioannidis K; Sigala F; Naka K; Kostidis S; Farmakis D; Tenta R; Kavantzas N; Bibli SI; Gikas E; Skaltsounis L; Kremastinos DT; Iliodromitis EK
J Mol Cell Cardiol; 2014 Apr; 69():4-16. PubMed ID: 24486195
[TBL] [Abstract][Full Text] [Related]
2. Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress.
Andreadou I; Sigala F; Iliodromitis EK; Papaefthimiou M; Sigalas C; Aligiannis N; Savvari P; Gorgoulis V; Papalabros E; Kremastinos DT
J Mol Cell Cardiol; 2007 Mar; 42(3):549-58. PubMed ID: 17223128
[TBL] [Abstract][Full Text] [Related]
3. Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein.
Andreadou I; Papaefthimiou M; Zira A; Constantinou M; Sigala F; Skaltsounis AL; Tsantili-Kakoulidou A; Iliodromitis EK; Kremastinos DT; Mikros E
NMR Biomed; 2009 Jul; 22(6):585-92. PubMed ID: 19308947
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy.
Efentakis P; Varela A; Chavdoula E; Sigala F; Sanoudou D; Tenta R; Gioti K; Kostomitsopoulos N; Papapetropoulos A; Tasouli A; Farmakis D; Davos CH; Klinakis A; Suter T; Cokkinos DV; Iliodromitis EK; Wenzel P; Andreadou I
Cardiovasc Res; 2020 Mar; 116(3):576-591. PubMed ID: 31228183
[TBL] [Abstract][Full Text] [Related]
5. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
[TBL] [Abstract][Full Text] [Related]
6. Short-term and long-term models of doxorubicin-induced cardiomyopathy in rats: A comparison of functional and histopathological changes.
O'Connell JL; Romano MM; Campos Pulici EC; Carvalho EE; de Souza FR; Tanaka DM; Maciel BC; Salgado HC; Fazan-Júnior R; Rossi MA; Simões MV
Exp Toxicol Pathol; 2017 Apr; 69(4):213-219. PubMed ID: 28153388
[TBL] [Abstract][Full Text] [Related]
7. Aliskiren attenuates myocardial apoptosis and oxidative stress in chronic murine model of cardiomyopathy.
Rashikh A; Ahmad SJ; Pillai KK; Kohli K; Najmi AK
Biomed Pharmacother; 2012 Mar; 66(2):138-43. PubMed ID: 22386366
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Effects of Liraglutide, Oxytocin and Granulocyte Colony-Stimulating Factor in Doxorubicin-Induced Cardiomyopathy Model: An Experimental Animal Study.
Taşkıran E; Erdoğan MA; Yiğittürk G; Erbaş O
Cardiovasc Toxicol; 2019 Dec; 19(6):510-517. PubMed ID: 31054117
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
[TBL] [Abstract][Full Text] [Related]
10. The natural olive constituent oleuropein induces nutritional cardioprotection in normal and cholesterol-fed rabbits: comparison with preconditioning.
Andreadou I; Benaki D; Efentakis P; Bibli SI; Milioni AI; Papachristodoulou A; Zoga A; Skaltsounis AL; Mikros E; Iliodromitis EK
Planta Med; 2015 Jun; 81(8):655-63. PubMed ID: 25473920
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
12. Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats.
Moriyama T; Kemi M; Okumura C; Yoshihara K; Horie T
Toxicology; 2010 Jan; 268(1-2):89-97. PubMed ID: 20004697
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of rosmarinic acid on doxorubicin-induced testicular damage.
Uyeturk U; Uyeturk U; Firat T; Cetinkaya A; Kin Tekce B; Cakir S
Chemotherapy; 2014; 60(1):7-12. PubMed ID: 25301265
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of tadalafil on left ventricular dysfunction in doxorubicin-induced cardiomyopathy.
Jin Z; Zhang J; Zhi H; Hong B; Zhang S; Guo H; Li L
J Cardiol; 2013 Aug; 62(2):110-6. PubMed ID: 23731918
[TBL] [Abstract][Full Text] [Related]
15. Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply.
Tokarska-Schlattner M; Zaugg M; da Silva R; Lucchinetti E; Schaub MC; Wallimann T; Schlattner U
Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H37-47. PubMed ID: 15764680
[TBL] [Abstract][Full Text] [Related]
16. Respiratory chain deficiency precedes the disrupted calcium homeostasis in chronic doxorubicin cardiomyopathy.
Lebrecht D; Kirschner J; Geist A; Haberstroh J; Walker UA
Cardiovasc Pathol; 2010; 19(5):e167-74. PubMed ID: 19747854
[TBL] [Abstract][Full Text] [Related]
17. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress.
Li W; Xu B; Xu J; Wu XL
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of aliskiren in doxorubicin-induced acute cardiomyopathy in rats.
Rashikh A; Abul Kalam Najmi ; Akhtar M; Mahmood D; Pillai KK; Ahmad SJ
Hum Exp Toxicol; 2011 Feb; 30(2):102-9. PubMed ID: 20418268
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
[TBL] [Abstract][Full Text] [Related]
20. Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes.
Altieri P; Barisione C; Lazzarini E; Garuti A; Bezante GP; Canepa M; Spallarossa P; Tocchetti CG; Bollini S; Brunelli C; Ameri P
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26746999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
